Significant declines in the ratio on ESAT-6/CFP-10-specific CD4+ T-cells were observed at two months of treatment in both HIV+TB (p = 0.02, Figure 8B) and HIV−TB (p = 0.004, Figure 8C). The gene discussed is CD4; the disease is tuberculosis.